Author

Jonathan C. Jacobson

Observed names: J. Jacobson, J.C. Jacobson, Jacobson, Jonathan, Jonathan Jacobson

Institutions: Royal Children's Hospital, Murdoch Children's Research Institute

Observed institutions: The Royal Melbourne Hospital, Royal Children's Hospital, The University of Melbourne, Peter Doherty Institute, Murdoch Children's Research Institute

ORCID: 0000-0001-8784-7922

Observed ORCID: 0000-0001-8784-7922

OpenAlex ID: A5001801639

Synergism and Antagonism of Bacterial-Viral Coinfection in the Upper Respiratory Tract

2022 · Sam Manna, Julie McAuley, et al. · mSphere · 58

Hyperimmune Bovine Colostrum as a Low-Cost, Large-Scale Source of Antibodies with Broad Neutralizing Activity for HIV-1 Envelope with Potential Use in Microbicides

2012 · Marit Kramski, Adam K. Wheatley, et al. · Antimicrobial Agents and Chemotherapy · 57

Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells

2016 · Lachlan R. Gray, Hung On, et al. · Journal of NeuroVirology · 35

HIV latency reversing agents act through Tat post translational modifications

2018 · Georges Khoury, Talia M. Mota, et al. · Retrovirology · 31

Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models

2019 · William Nguyen, Jonathan Jacobson, et al. · Journal of Medicinal Chemistry · 15

Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children?

2022 · Thomas Abrehart, Randy Suryadinata, et al. · Paediatric Respiratory Reviews · 11

HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro

2018 · Michael A. Moso, Jenny L. Anderson, et al. · AIDS · 9

Optimization of 5-substituted thiazolyl ureas and 6-substituted imidazopyridines as potential HIV-1 latency reversing agents

2020 · William Nguyen, Jonathan Jacobson, et al. · European Journal of Medicinal Chemistry · 5

Evaluation of a multiplex-qPCR for paediatric pleural empyema—An observational study in hospitalised children

2024 · Jonathan Jacobson, Loraine Fabri, et al. · PLoS ONE · 2

Development of novel HIV-1 latency reversing agents

2018 · Jonathan Jacobson · Minerva Access (University of Melbourne)

4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.

2017 · J. Jacobson, B. Sleebs, et al. · Journal of Virus Eradication

37 Novel pathways of Tat expression identify new targets for reactivation of latent HIV-1

2016 · M. Lee, J. Jacobson, et al. · Journal of Virus Eradication

26 A novel assay to evaluate the response of patient-derived virus to latency-reversing agents ex vivo

2016 · H. Lu, M. Moso, et al. · Journal of Virus Eradication

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal

2016 · T.M. Mota, G. Khoury, et al. · Journal of Virus Eradication

Works count: 21

Citation count: 222

H-index: 7

I10-index: 6